Kitov pharma ltd. (KTOV)
CashFlow / Yearly
Dec'17Dec'16Dec'15
Cash flows from operating activities:
Loss for the period

13,008

12,125

4,202

Adjustments:
Depreciation

4

2

1

Finance expenses (income), net

947

4,942

133

Share-based payments

2,308

400

59

Expenses (income) in regards with settlement with a minority shareholder of a subsidiary (see Note 4)

1,000

0

0

Expenses in regard to a strategic cooperation agreement

0

250

417

Total adjustments

-8,749

-6,531

-3,592

Changes in assets and liabilities:
Changes in receivables

-273

0

197

Changes in accounts payables

-491

-138

-152

Changes in other payables

745

357

54

Changes in post - employment benefit liabilities

141

50

185

Changes in assets and liabilities, total

122

269

284

Net cash used in operating activities

-8,627

-6,262

-3,308

Cash flows from investing activities:
Acquisition of subsidiary, net of cash acquired

-1,732

0

0

Decrease (increase) in short term deposits

4,411

-7,899

0

Acquisition of fixed assets

13

10

9

Net cash used in investing activities

2,772

-7,771

-9

Cash flows from financing activities:
Proceeds from warrants exercised

0

325

2

Repayment of short term bank credit

-16

0

0

Proceeds from issuance of shares and ADSs

2,419

6,287

14,942

Share and ADS issuance expenses paid

245

1,065

2,059

Proceeds from issuance of warrants

1,107

5,713

190

Warrants issuance expenses paid

114

968

10

Repayment of loans from related parties

130

0

294

Interest paid

26

6

145

Interest received

106

138

0

Net cash provided by (used in) financing activities

2,995

10,286

12,632

Net increase (decrease) in cash and cash equivalents

-2,860

-3,747

9,315

Effect of translation adjustments on cash and cash equivalents

49

-53

-70